Schwazze, (OTCQX: SHWZ) (NEO: SHWZ), a premier vertically integrated, multi-state operating cannabis company with assets in Colorado and New Mexico is proud to announce that its Colorado dispensary, Star Buds has become the first cannabis company to place its logo on a professional sports team’s uniform as the official sponsor of the Colorado Summit (Summit), Colorado’s first professional ultimate disc team.
On Wednesday, May 4th, Colorado Summit made history by revealing the first jersey in professional sports history to feature a cannabis logo — Star Buds dispensary. Established in 2013, Star Buds excels in customer service, offers competitive prices, and a wide selection of cannabis products and strains, including our signature Cannabis Cup-winning Pootie Tang sativa. Star Buds is also the official sponsor of the Colorado Summit Beer Garden located in the University of Denver’s Peter Barton Stadium.
“We’re incredibly proud to be the first cannabis company to sponsor Colorado’s first professional ultimate disc team and hope this will drive a movement toward the acceptance of cannabis in professional sports,” said Justin Dye, CEO and Chairman of Schwazze.
The Colorado Summit’s season kicks off on Saturday, May 7th in Seattle at 6 PM MT. The Summit will play their first home game on Memorial Day Weekend, Saturday, May 28th at 7 PM MT at the University of Denver’s Peter Barton Stadium (at the base of the DU clocktower). Fox Sports will be broadcasting two of the Colorado Summit’s home games live nationally on FS2 this season. All of their games can be streamed online on AUDL.TV.
Ultimate was created in 1969 and is now the fastest-growing sport in the world. The fast-paced, high-flying sport is being considered for admission to the 2028 Olympics.
Tickets to all home games can be purchased at TheColoradoSummit.com. Replica Colorado Summit Jerseys can be purchased at VIIapparel.co.
Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to take its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to incorporate climate-conscious best practices.
Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth.
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,”, “predicts,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; (v) difficulties in securing regulatory approval to market our products and product candidates; (vi) our ability to successfully execute our growth strategy in Colorado and outside the state, (vii) our ability to consummate the acquisition described in this press release or to identify and consummate future acquisitions that meet our criteria, (viii) our ability to successfully integrate acquired businesses and realize synergies therefrom, (ix) the ongoing COVID-19 pandemic, * the timing and extent of governmental stimulus programs, (xi) the uncertainty in the application of federal, state and local laws to our business, and any changes in such laws, and * out ability to satisfy the closing conditions for the private finding described in this press release. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.
SOURCE Medicine Man Technologies, Inc.